December 5–6, 2003
Toulouse, France
More information coming soon
List of communications
Claude Crampes (IDEI and GREMAQ), “The Pricing of Pharmaceuticals Facing Parallel Imports”, Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, December 5–6, 2003.
Sara F. Ellison (Massachusetts Institute of Technology), “Countervailing Power in Wholesale Pharmaceuticals”, Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, December 5–6, 2003.
Mark Gersovitz (The Johns Hopkins University), “The Economical Control of Infectious Diseases”, Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, December 5–6, 2003.
Brigitte Granville (Queen Mary, University of London), “Markets for Pharmaceuticals and Absorptive Capacity in Developing Nations : The Case of Transition Economies”, Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, December 5–6, 2003.
William Jack (Georgetown University), “Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?”, Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, December 5–6, 2003.
Kristina M. Lybecker (Drexel University), “Rx Roulette : Counterfeit Pharmaceuticals in Developing Nations”, Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, December 5–6, 2003.
Stéphane Mechoulan (NBER), “Intellectual Property & External Consumption Effects : Generalizations from Pharmaceuticals Markets”, Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, December 5–6, 2003.
Alice Mesnard (ARQADE, IDEI, University of Toulouse), “Migration and Quarantine in the Presence of Asymmetric Information about Risk of Infectious Disease”, Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, December 5–6, 2003.
Shyama V. Ramani (INRA, Grenoble), “TRIPS and its Possible Impact on the Indian Biopharmaceutical Industry”, Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, December 5–6, 2003.
F. M. Scherer (Princeton University), “Global Welfare in Pharmaceutical Patenting”, Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, December 5–6, 2003.
Christopher M. Snyder (George Washington University), “Are Drugs More Profitable than Vaccines?”, Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, December 5–6, 2003.